Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saroja Pharma Industries IndiaNSE:SAROJA +3.15%15 Operating Margin % is 4.98% as of Mar. 2025, which is at its 10-year median of 4.98. GuruFocus rates NSE:SAROJA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 958 Drug Manufacturers companies, Saroja Pharma Industries India ranks worse than 57.52% on this metric.
The historical rank and industry rank for Saroja Pharma Industries India's Operating Margin % or its related term are showing as below:
NSE:SAROJA'
s Operating Margin % Range Over the Past 10 Years
Min: 3.5 Med: 4.98 Max: 6.06
Current: 4.98
NSE:SAROJA's Operating Margin % is ranked worse than 57.52% of 958
companies
in the Drug Manufacturers industry
Industry Median: 7.34
vs NSE:SAROJA: 4.98
Saroja Pharma Industries India (NSE:SAROJA) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Saroja Pharma Industries India Operating Margin % Related Terms
Saroja Pharma Industries India Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India Operating Margin % Chart
Saroja Pharma Industries India Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Operating Margin %
3.50
3.70
5.29
6.06
4.98
Saroja Pharma Industries India Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Operating Margin %
3.50
3.70
5.29
6.06
4.98
NSE:SAROJA vs ZTS: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saroja Pharma Industries India Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Saroja Pharma Industries India's Operating Margin % falls into.
Saroja Pharma Industries India Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India (NSE:SAROJA) has a Operating Margin % of 4.98% as of Mar. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Saroja Pharma Industries India and its competitors. This is near median its historical median of 4.98. Over the past decade, Saroja Pharma Industries India's Operating Margin % has ranged from 3.50 to 6.06. According to the industry distribution chart, Saroja Pharma Industries India ranks #551 out of 958 companies in the Drug Manufacturers industry, placing it in the top 57.5%.
Is Saroja Pharma Industries India's Operating Margin % too high?
Saroja Pharma Industries India's current Operating Margin % of 4.98% is near median its 10-year median of 4.98. Over the past 10 years, this metric has ranged from a low of 3.50 to a high of 6.06. The Drug Manufacturers industry median Operating Margin % is 7.34. Saroja Pharma Industries India's value of 4.98% is 32.2% below this industry median. Based on the distribution chart, Saroja Pharma Industries India ranks #551 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Saroja Pharma Industries India has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Saroja Pharma Industries India ranks #551 out of 958 companies for Operating Margin %. This places Saroja Pharma Industries India in the lower half of its industry. The industry median Operating Margin % is 7.34. Saroja Pharma Industries India's value of 4.98% is 32.2% below this benchmark. Historically, Saroja Pharma Industries India's own Operating Margin % has ranged from 3.50 to 6.06 over the past decade. While the company's 10-year median is 4.98 vs. the industry median of 7.34, Saroja Pharma Industries India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.34, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saroja Pharma Industries India's current Operating Margin % of 4.98% is 32.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Saroja Pharma Industries India and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saroja Pharma Industries India's current Operating Margin % is 4.98%, which is near median its own 10-year median of 4.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current Operating Margin % of 4.98%. The current Operating Margin % is 4.98%, which is near median its 10-year median of 4.98 and 32.2% below the Drug Manufacturers industry median of 7.34. Saroja Pharma Industries India's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current Operating Margin % is 4.98% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score
Get the complete analysis for NSE:SAROJA
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAROJA has been successfully added to your 
